Abstract:Background: Endometrial cancer is a multifactorial disease with inflammatory, metabolic and potentially microbial cues involved in disease pathogenesis. The endometrial cancer microbiome has been poorly characterised so far and studies have often overestimated bacterial biomass due to lack of integration of appropriate contamination controls. There is also a scarcity of evidence on the functionality of microbial microenvironments in endometrial cancer. This work addresses that knowledge gap by interrogating the genuine, contamination-free microbial signatures in the female genital tract and rectum of women with endometrial cancer and the mechanistic role of microbiome on carcinogenic processes. Results: Here we sampled different regions of the reproductive tract (vagina, cervix, endometrium, fallopian tubes and ovaries) and rectum of 61 patients (37 endometrial cancer; 24 benign controls). We performed 16S rRNA gene sequencing of the V1-V2 hypervariable regions and qPCR of the 16S rRNA gene to qualitatively and quantitatively assess microbial communities and used 3D benign and endometrial cancer organoids to evaluate the effect of microbial products of L. crispatus, which was found depleted in endometrial cancer patients following primary analysis, on endometrial cell proliferation and inflammation. We found that the upper genital tract of a subset of women with and without endometrial cancer harbour microbiota quantitatively and compositionally distinguishable from background contaminants. Endometrial cancer was associated with reduced cervicovaginal and rectal bacterial load together with depletion of Lactobacillus species relative abundance, including L. crispatus, increased bacterial diversity and enrichment of Porphyromonas, Prevotella, Peptoniphilus and Anaerococcus in the lower genital tract and endometrium. Treatment of benign and malignant endometrial organoids with L. crispatus conditioned media exerted an anti-proliferative effect at high concentrations but had minimal impact on cytokine and chemokine profiles. Conclusions: Our findings provide evidence that the upper female reproductive tract of some women contains detectable levels of bacteria, the composition of which is associated with endometrial cancer. Whether this is a cause or consequence of cancer pathophysiology and what is the functional significance of this finding remain to be elucidated to guide future screening tools and microbiome-based therapeutics. Video Abstract.

Oral, Vaginal, and Stool Microbial Signatures in Patients With Endometriosis as Potential Diagnostic Non-Invasive Biomarkers: A Prospective Cohort Study

Identification of distinct stool metabolites in women with endometriosis for non-invasive diagnosis and potential for microbiota-based therapies

Microbial signatures and continuum in endometrial cancer and benign patients

Vaginal microbiome dysbiosis as a novel noninvasive biomarker for detection of chronic endometritis in infertile women

Endometrial Microbiota in Women with and Without Adenomyosis: A Pilot Study

Endometriosis specific vaginal microbiota links to urine and serum N-glycome

A More Diverse Cervical Microbiome Associates with Better Clinical Outcomes in Patients with Endometriosis: A Pilot Study

Intricate Connections between the Microbiota and Endometriosis

Microbiota composition and distribution along the female reproductive tract of women with endometriosis.

Gut microbiota and microbiota-derived metabolites promotes endometriosis

Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis

The Endometrial Microbiota: Challenges and Prospects

Gut Microbiome–Estrobolome Profile in Reproductive-Age Women with Endometriosis

Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis

Serum Metabolites as Diagnostic Biomarkers in Patients with Endometriosis

Gut microbiome in endometriosis: a cohort study on 1000 individuals

Is there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?

Validation of a Salivary miRNA Signature of Endometriosis - Interim Data

Gut and Vaginal Microbiota in the Endometriosis: Systematic Review and Meta-Analysis

Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis

The colonized microbiota composition in the peritoneal fluid in women with endometriosis